Assessment of renal functions in patients of chronic liver disease

H K Aggarwal1, Deepak Jain1, Suhas Singla1

  • 1a Department of Medicine and Division of Nephrology , Pt. B.D. Sharma University of Health Sciences , Rohtak , Haryana , India.

Renal Failure
|September 5, 2015
PubMed

Insights

Renal impairment is common in chronic liver disease (CLD) patients, especially those with advanced disease and complications like portal hypertension. Vigilance for kidney issues is crucial in managing CLD.

Area of Science:

  • Nephrology
  • Hepatology
  • Internal Medicine

Background:

  • Renal involvement is a severe complication of chronic liver disease (CLD), significantly increasing mortality and morbidity.
  • Homeostatic disruptions in CLD can cause direct kidney injury or circulatory issues, leading to renal impairment.

Purpose of the Study:

  • To investigate the prevalence and types of renal impairment in cirrhotic patients.
  • To identify clinical factors associated with renal dysfunction in chronic liver disease.

Main Methods:

  • A study included 100 consecutive cirrhotic patients.
  • Patients were assessed for structural and functional renal failure, classifying them into pre-renal, intra-renal, and hepatorenal syndrome (HRS).

Main Results:

  • 37% of patients presented with renal dysfunction.
  • Pre-renal failure was most common (30 patients), followed by intrinsic renal disease (6 patients) and structural renal disease (1 patient).
  • Decompensating conditions like portal hypertension, jaundice, GI bleeding, hepatic encephalopathy, and infections (SBP/sepsis) were linked to higher rates of renal derangements.

Conclusions:

  • Renal impairment is frequent in advanced chronic liver disease.
  • Portal hypertension and signs of decompensation increase the risk of renal issues.
  • Increased vigilance for renal derangements is recommended due to rising CLD incidence and improved survival rates.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
337
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
549
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
308
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
585
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
317